Ocular Therapeutix gets subpoena from SEC over eye pain drug

Published 6y ago

(Reuters) – Ocular Therapeutix Inc said on Friday the U.S. Securities and Exchange Commission (SEC) had issued a subpoena seeking information about the company’s eye-pain drug Dextenza. Shares of the company were down 7.2 percent at $4.25 in after-marketing tr... More »